|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/10/19 Emmaus Life Sciences, Inc. S-4/A 84:17M Edgar Agents LLC/FA |
Document/Exhibit Description Pages Size
1: S-4/A Amendment No. 1 to Registration Statement HTML 4.06M
2: EX-5.1 Legal Opinion of Dentons Us LLP HTML 28K
3: EX-23.1 Consent of Marcum LLP, Independent Registered HTML 23K
Public Accounting Firm
4: EX-23.2 Consent of Singerlewak LLP, Independent Registered HTML 22K
Public Accounting Firm
5: EX-23.4 Consent of Thinkequity HTML 23K
8: EX-99.10 Consent of Wei Peu Zen to Be Named as A Director HTML 23K
6: EX-99.2 Form of Mynd Analytics, Inc. Proxy Card HTML 21K
7: EX-99.3 Form of Emmaus Life Sciences, Inc. Proxy Card HTML 21K
15: R1 Document and Entity Information HTML 41K
16: R2 Unaudited Condensed Consolidated Balance Sheets HTML 130K
17: R3 Unaudited Condensed Consolidated Balance Sheets HTML 53K
(Parenthetical)
18: R4 Unaudited Condensed Consolidated Statements of HTML 86K
Operations
19: R5 Unaudited Condensed Consolidated Statements of HTML 128K
Stockholders' Equity
20: R6 Unaudited Condensed Consolidated Statements of HTML 125K
Cash Flows
21: R7 Consolidated Statements of Cash Flows HTML 26K
(Parenthetical)
22: R8 Organization, Nature of Operations and Going HTML 42K
Concern Uncertainty
23: R9 Summary of Significant Accounting Policies HTML 149K
24: R10 Revenue Recognition HTML 41K
25: R11 Accounts Receivable HTML 30K
26: R12 Long - Term Borrowings and Other Note Payable HTML 33K
27: R13 Acquisition HTML 52K
28: R14 Reverse Merger HTML 36K
29: R15 Stockholders' Equity HTML 224K
30: R16 Convertible Preferred Stock HTML 41K
31: R17 Income Taxes HTML 49K
32: R18 Related Party Transactions HTML 37K
33: R19 Loss Per Share HTML 45K
34: R20 Commitments and Contingent Liabilities HTML 38K
35: R21 Significant Customers HTML 25K
36: R22 Subsequent Events HTML 36K
37: R23 Summary of Significant Accounting Policies HTML 222K
(Policies)
38: R24 Summary of Significant Accounting Policies HTML 29K
(Tables)
39: R25 Revenue Recognition (Tables) HTML 29K
40: R26 Accounts Receivable (Tables) HTML 30K
41: R27 Long - Term Borrowings and Other Notes Payable HTML 26K
(Tables)
42: R28 Acquisition (Tables) HTML 43K
43: R29 Stockholders' Equity (Tables) HTML 153K
44: R30 Income Taxes (Tables) HTML 49K
45: R31 Loss Per Share (Tables) HTML 44K
46: R32 Commitments and Contingent Liabilities (Tables) HTML 32K
47: R33 Organization, Nature of Operations and Going HTML 45K
Concern Uncertainty (Details)
48: R34 Summary of Significant Accounting Policies HTML 35K
(Details)
49: R35 Summary of Significant Accounting Policies HTML 33K
(Details Narrative)
50: R36 Summary of Significant Accounting Policies HTML 88K
(Details Narrative 1)
51: R37 Revenue Recognition (Details) HTML 30K
52: R38 Revenue Recognition (Details Narrative) HTML 31K
53: R39 Accounts Receivable, Net (Details) HTML 32K
54: R40 Long - Term Borrowings and Other Notes Payable HTML 30K
(Details)
55: R41 Long - Term Borrowings and Other Note Payables HTML 54K
(Details Narrative)
56: R42 Acquisition (Details) HTML 71K
57: R43 Acquisition (Details 1) HTML 33K
58: R44 Acquisition (Details Narrative) HTML 60K
59: R45 Reverse Merger (Details Narrative) HTML 42K
60: R46 Stockholders' Equity (Details) HTML 43K
61: R47 Stockholders' Equity (Details 1) HTML 31K
62: R48 Stockholders' Equity (Details 2) HTML 59K
63: R49 Stockholders' Equity (Details 3) HTML 130K
64: R50 Stockholders' Equity (Details 4) HTML 53K
65: R51 Stockholders' Equity (Details 5) HTML 37K
66: R52 Stockholders' Equity (Details 6) HTML 48K
67: R53 Stockholders' Equity (Details 7) HTML 67K
68: R54 Stockholders' Equity (Details Narrative) HTML 313K
69: R55 Stockholders' Equity (Details Narrative 1) HTML 140K
70: R56 Convertible Preferred Stock (Details Narrative) HTML 67K
71: R57 Income Taxes (Details) HTML 47K
72: R58 Income Taxes (Details 1) HTML 45K
73: R59 Income Taxes (Details 2) HTML 49K
74: R60 Income Taxes (Details 3) HTML 44K
75: R61 Income Taxes (Details Narrative) HTML 39K
76: R62 Related Party Transactions (Details Narrative) HTML 78K
77: R63 Loss Per Share (Details) HTML 56K
78: R64 Commitments and Contingent Liabilities (Details) HTML 28K
79: R65 Commitments and Contingent Liabilities (Details HTML 45K
Narrative)
80: R66 Significant Customers (Details Narrative) HTML 33K
81: R67 Subsequent Events (Details Narrative) HTML 86K
83: XML IDEA XML File -- Filing Summary XML 148K
82: EXCEL IDEA Workbook of Financial Reports XLSX 131K
9: EX-101.INS XBRL Instance -- mynd-20190331 XML 2.42M
11: EX-101.CAL XBRL Calculations -- mynd-20190331_cal XML 208K
12: EX-101.DEF XBRL Definitions -- mynd-20190331_def XML 865K
13: EX-101.LAB XBRL Labels -- mynd-20190331_lab XML 1.34M
14: EX-101.PRE XBRL Presentations -- mynd-20190331_pre XML 1.09M
10: EX-101.SCH XBRL Schema -- mynd-20190331 XSD 221K
84: ZIP XBRL Zipped Folder -- 0001213900-19-010448-xbrl Zip 223K
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement of MYnd Analytics, Inc. on Form S-4 of our report dated December 11, 2018, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of MYnd Analytics, Inc. as of September 30, 2018 and 2017 and for the years ended September 30, 2018 and 2017, which report appears in the Joint Proxy Statement/Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Joint Proxy Statement/Prospectus.
| /s/ Marcum LLP | |
| Marcum LLP | |
| Costa Mesa, California | |
| June 10, 2019 |
| This ‘S-4/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 6/10/19 | 8-K | ||
| 12/11/18 | 10-K | |||
| 9/30/18 | 10-K | |||
| 9/30/17 | 10-K | |||
| List all Filings | ||||